Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report
- PMID: 26593089
- PMCID: PMC4655488
- DOI: 10.1186/s13256-015-0741-2
Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report
Abstract
Introduction: Unexplained hyperammonemic coma in adults can be a medical dilemma in the absence of triggering factors and known comorbidities. Ornithine transcarbamylase deficiency presents most commonly with hyperammonemic coma. Although a rare disorder, ornithine transcarbamylase deficiency is the most common of the urea cycle disorders, which can occur both in children, and less commonly, in adults. The urea cycle disorder is usually acquired as an X-linked trait, and very rarely, similar to our reported case, may be acquired as a "new" mutation. Mutations that lead to later-onset presentations may lead to life-threatening disease and may be unrecognized, particularly when the first clinical symptoms occur in adulthood.
Case presentation: We report the case of a previously healthy 17-year-old white man who developed a prolonged seizure and a rapid decline in mental status leading to coma over a 3-day period. Analysis of the OTC gene showed a 119G variant, which was identified in exon 2 of the OTC gene by sequencing.
Conclusions: A diagnosis of ornithine transcarbamylase deficiency should be considered in adult patients who present with unexplained hyperammonemic coma and for all adult patients presenting with cryptogenic new-onset seizure and laboratory finding of elevated blood ammonia levels. This reported case highlights the importance of early recognition of this potentially reversible cause of life-threatening encephalopathy, as timely recognition and appropriate treatment can be lifesaving.
Figures




Similar articles
-
[Fulminant coma: think hyperammonemia and urea cycle disorders].Ann Fr Anesth Reanim. 2002 Dec;21(10):820-3. doi: 10.1016/s0750-7658(02)00803-1. Ann Fr Anesth Reanim. 2002. PMID: 12534125 French.
-
Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.J Perinatol. 2011 Oct;31(10):682-4. doi: 10.1038/jp.2011.23. J Perinatol. 2011. PMID: 21956151
-
Hyperammonemic coma in a patient with late-onset OTC deficiency.Pediatr Med Chir. 2014 Jun 30;36(3):9. doi: 10.4081/pmc.2014.9. Pediatr Med Chir. 2014. PMID: 25573644
-
[Hyperammonemia type II as an example of urea cycle disorder].Wiad Lek. 2006;59(7-8):512-5. Wiad Lek. 2006. PMID: 17209350 Review. Polish.
-
Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.J Genet Genomics. 2015 May 20;42(5):181-94. doi: 10.1016/j.jgg.2015.04.003. Epub 2015 May 19. J Genet Genomics. 2015. PMID: 26059767 Free PMC article. Review.
Cited by
-
Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review.Neurohospitalist. 2019 Jan;9(1):30-36. doi: 10.1177/1941874418764817. Epub 2018 Mar 26. Neurohospitalist. 2019. PMID: 30671162 Free PMC article.
-
A Mysterious Case of Recurrent Acute Hyperammonemic Encephalopathy.Cureus. 2020 Mar 31;12(3):e7484. doi: 10.7759/cureus.7484. Cureus. 2020. PMID: 32351862 Free PMC article.
-
Management of late onset urea cycle disorders-a remaining challenge for the intensivist?Ann Intensive Care. 2021 Jan 6;11(1):2. doi: 10.1186/s13613-020-00797-y. Ann Intensive Care. 2021. PMID: 33409766 Free PMC article. Review.
-
Effect of Ornithine Transcarbamylase (OTC) Deficiency on Pregnancy and Puerperium.Diagnostics (Basel). 2022 Feb 5;12(2):415. doi: 10.3390/diagnostics12020415. Diagnostics (Basel). 2022. PMID: 35204506 Free PMC article.
-
Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.Case Rep Med. 2016;2016:8512721. doi: 10.1155/2016/8512721. Epub 2016 Sep 21. Case Rep Med. 2016. PMID: 27738433 Free PMC article.
References
-
- Thomas GH. High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorder. Am J Hum Genet. 1996;58:1364–8. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915043/. Accessed 20 April 2015. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical